Key Points
- Federal Circuit issued precedential opinion in Hospira Inc. v. Fresenius Kabi USA, LLC that affirmed obviousness of a liquid drug patent claim, encouraging future patent challengers to raise the issue of...more
1/24/2020
/ Appeals ,
Claim Limitations ,
Extrinsic Evidence ,
Inherency ,
Obviousness ,
Orange Book ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Precedential Opinion ,
Prior Art
This morning, the Food and Drug Administration (FDA) opened a public docket and requested comments on its proposed criteria for expedited review of "first generic" Abbreviated New Drug Applications (ANDAs). The comment period...more
The US Supreme Court issued two anticipated decisions on June 2, 2014, relating to the US Court of Appeals for the Federal Circuit's standards for indefiniteness and induced infringement.
In the first, Nautilus, Inc....more